 7. Subjects on statins will need to be on less than maximal dose e.g. 80 mg per day for simvastatin or atorvastatin. Subjects will also need to have been on a stable dose of statin therapy for at least 1 month prior to enrollment and continue their currently prescribed statin at the same dose throughout the study. If it is deemed safe by the patients primary physician and by the principal investigator, patients on maximal statin therapy usually 80 mgday may reduce their dose of statin therapy to a sub maximal dose usually 40 mgday for 4 weeks prior to screening for enrollment. 